TRANSFERRING ECONOMIC DATA FROM A DEVELOPED TO DEVELOPING COUNTRY SETTING TO CONDUCT HTA: THE CASE OF TAMOXIFEN FOR THE ADJUVANT TREATMENT OF ADVANCED BREAST CANCER AMONG PREMENOPAUSAL WOMEN IN GHANA

被引：0
|
作者：
Addo, R. [1 ]
Goodall, S. [2 ]
Hall, J. [1 ]
Haas, M. [1 ]
机构：
[1] Univ Technol Sydney, Haymarket, Australia
[2] Univ Technol Sydney, Sydney, NSW, Australia
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.173
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN104
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 3 条
  • [1] The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor-Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women
    Addo, Rebecca
    Haas, Marion
    Goodall, Stephen
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2021, 25 : 196 - 205
  • [2] Mature data (> 25 years) on 2 years adjuvant tamoxifen treatment in premenopausal women with breast cancer: Time to re-emphasize the progesterone receptor as predictive factor?
    Ekholm, Maria
    Bendahl, Par-Ola
    Ferno, Marten
    Nordenskjold, Bo
    Stal, Olle
    Ryden, Lisa
    [J]. CANCER RESEARCH, 2015, 75
  • [3] How compliant are patients with oral hormonal therapies? Data from a randomized, placebo controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (NCIC CTG MA.12)
    Bramwell, V. H. C.
    Pritchard, K., I
    Tu, D.
    Tonkin, K.
    Vachhrajani, H.
    Robert, J.
    Arnold, A.
    Vandenberg, T. A.
    O'Reilly, S. E.
    Graham, B.
    Shepeherd, L. E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S144 - S144
1